In a major boost to rural health, iKure has secured $1.8 million in Pre-Series A funding from the Philips Foundation, World Diabetes Foundation, and other global leaders to scale its technology-driven primary healthcare model.
- Secured USD 1.8 million from Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Prourgn LLC.
- Investment focuses on scaling AI-enabled clinical decision support and expanding field workforce.
- Currently serves 36 million+ people across 7,900 villages in 11 Indian states.
iKure Techsoft Private Limited has announced a significant milestone in its journey to democratize healthcare in India, securing USD 1.8 million in Pre-Series A funding. The investment comes from a consortium of globally respected entities, including the Philips Foundation, World Diabetes Foundation, Bayer Foundation (via We Share Forward), and Prourgn LLC from Japan. Each investor independently validated iKure's delivery model and its capacity for large-scale execution.
Unlike traditional healthcare models that treat a single check-up as the end goal, iKure focuses on longitudinal care. This shift is critical because non-communicable diseases (NCDs), such as diabetes and hypertension, are now the leading causes of death in India. These conditions require ongoing monitoring and consistent follow-ups, which are often missing in rural health infrastructure.
Why This Matters
BozokMedia analysis shows that while India has successfully increased screening rates, the systemic failure lies in patient retention and follow-up care. iKure addresses this gap by deploying Community Health Activists (CHAs) who become trusted local figures. By integrating clinical data with community outreach, iKure ensures that a diagnosis is not just a piece of paper but the start of a managed health journey.
"Every part of this investment is intended to ensure that patients remain connected to care long after their first consultation... That accountability is what we built this company around." - Sujay Santra, Founder and CEO, iKure
The company's operational scale is impressive, covering 11 states and recording over 4.5 million patient interactions. This is achieved through WHIMS, a proprietary digital health platform that unifies primary healthcare hubs, pharmacies, and telemedicine. The model is further strengthened by over 10,000 women-led Self-Help Groups (SHGs), allowing the service to penetrate deep into households where clinical services typically struggle to reach.
The newly acquired funds are earmarked for expanding diagnostic capacity and enhancing the WHIMS platform. Specifically, the company will integrate AI-enabled clinical decision support to provide field workers with early warnings regarding patient risks. This technological leap will allow clinical teams to manage larger populations with higher precision.
Historically, healthcare delivery in India has been fragmented by geography and infrastructure gaps. iKure has proven its resilience by operating in diverse terrains, from flood-prone coasts to landlocked regions. This adaptability has positioned the company to move from regional coverage toward deeper integration with state and national health planning.
| Feature | Traditional Model | iKure Model |
|---|---|---|
| Care Approach | Episodic (Single Visit) | Longitudinal (Continuous) |
| Data Management | Paper-based/Fragmented | Unified WHIMS Digital Platform |
| Community Reach | Hospital-centric | CHA & SHG-led Outreach |
Frequently Asked Questions
1. What is the WHIMS platform?
WHIMS is iKure's proprietary digital health platform that integrates patient records and provides data-driven support to community health workers.
2. How will the $1.8 million funding be used?
The funds will be used to increase the number of health workers, expand healthcare hubs, and implement AI-driven clinical decision tools.
